Better Sleep Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age12-18
SponsorChildren's Hospital Los Angeles
About this trial
The overall aim of this proposal is a confirmatory efficacy trial sufficiently powered and designed to test the hypothesis that improving the relationship between biological circadian timing and waketime, a novel modifiable target, improves depression outcomes in a subgroup of adolescents with depression and a misaligned relationship between biological circadian timing and waketime utilizing a cognitive-behavioral sleep intervention.
Eligibility criteria
Qualifiers
None
Disqualifiers
mental health/behavioral symptoms that would preclude productive engagement in study assessments or intervention (e.g., active psychosis; Bipolar Disorder; drug dependence
severe or unstable medical or psychiatric condition such that treatment has changed within the last month or is expected to change during the course of the study or that would preclude ability to adhere to study procedures (e.g. terminal end-stage cancer)
current use of medications or herbs with known effects on sleep
plan to undergo or have had medication change in the last 8 weeks
Trial design
Treatments tested in this trial
- TranS-C
- Psychoeducation
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Children's Hospital Los Angeles
Lead sponsor
Stanford University
Collaborator
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov